Menu
Recruiting NCT06668649

Polish Version Fatigue Severity Scale

Observational Multiple Sclerosis Amyotrophic Lateral Sclerosis Stroke, Ischemic

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Testing with Questionnaires.
Who it may be relevant to
Registry conditions: Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Stroke, Ischemic. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Poland
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Validation of Polish Language Version of Fatigue Severity Scale

Overview

Fatigue is one of main symptoms in multiple sclerosis, amyotrophic lateral sclerosis and other diseases with profound effect on quality of life and professional and social functioning. Not infrequent it is misdiagnosed as sleepiness or other symptom. Fatigue severity scale is a time efficient and easy to apply instrument to assess the impact of fatigue on patient's life. The aim of this study is to validate the Polish-language version of the Fatigue Severity Scale.

Detailed description

Fatigue is one of main symptoms in multiple sclerosis, amyotrophic lateral sclerosis, post-polio syndrome, stroke, parkinsonism as well as in the chronic fatigue syndrome. It has profound effect on quality of life and professional and social functioning and in multiple sclerosis it is described as the worst symptoms by the 50% of patients. It is defined as the difficulty in initiating and maintaining a sustained mental or physical activity. Not infrequent it is misdiagnosed as sleepiness or other symptom. Fatigue severity scale (FSS) is a time efficient and easy to apply instrument to assess the impact of fatigue on patient's life. It has been translated and validated in Turkish, Russian, Hindi, Portuguese, and many other languages. FSS is a short, nine-item self-report questionnaire. Each item is a Likert scale, scored from one to seven, where seven refers to the most severely expressed aspect of fatigue. The aim of this study is to validate the Polish-language version of the Fatigue Severity Scale (pFSS). This version has been created according to widely accepted, respective standards, including translation by two independent native Polish-language speakers with acquired knowledge of English and backward translation by two independent native English-language speakers with acquired knowledge of Polish as well as with the pretesting on ten patients.

Interventions

  • Diagnostic test Testing with Questionnaires
    Testing with following Questionnaires: pFSS, Polish-language version of Modified Fatigue Impact Scale, Visual Analogue Scale of Fatigue, EQ-5D-5L (EuroQol-5 dimension) questionnaire, Beck Depression Inventory II. In randomly selected 30 patients and 20 controls questionnaires will be administered twice with two weeks interval to assess the test-retest reliability.

Primary outcome measures

  • Internal Consistency [Time frame: Through study completion, an average of 1 year]
  • Validity [Time frame: Through study completion, an average of 1 year]
  • Reliability [Time frame: Through study completion, an average of 1 year]
Secondary outcome measures (4)
  • Impact of fatigue on quality of life - index [Time frame: Through study completion, an average of 1 year]
  • Impact of fatigue on quality of life - visual analogue scale [Time frame: Through study completion, an average of 1 year]
  • Impact of fatigue on depression [Time frame: Through study completion, an average of 1 year]
  • Difference in fatigue level between patients and controls [Time frame: Through study completion, an average of 1 year]

Eligibility criteria

Inclusion criteria

  • Diagnosis of definite multiple sclerosis or definite, laboratory-supported multiple sclerosis, or definite amyotrophic lateral sclerosis, or probable amyotrophic lateral sclerosis or probable, laboratory supported amyotrophic lateral sclerosis or ischemic stroke or - for healthy controls - lack of diseases, pharmacotherapy or habits, which could induce abnormal tiredness

Exclusion criteria

  • Presence of cognitive deficits or behavioral disorder, which could disturb participation in the study.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Case-control

Study locations

Poland · 2 centers
  • Jagiellonian University Medical College, Department of Neurology — Krakow
  • Institute of Psychiatry and Neurology — Warsaw

Publications

  • Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993 Dec;46(12):1417-32. doi: 10.1016/0895-4356(93)90142-n. PMID 8263569

Identifiers

NCT: NCT06668649 · JagiellonianU74

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗